Table 3.
Most cited items published in ckj in 2018
| Rank | Title | References |
|---|---|---|
| 1 | The European Renal Association – European Dialysis and Transplant Association (ERA–EDTA) Registry Annual Report 2015: a summary | Kramer et al. [31] |
| 2 | Patterns of progression of chronic kidney disease at later stages | Caravaca-Fontán et al. [32] |
| 2 | Pretreatment of enteral nutrition with sodium polystyrene sulfonate: effective, but beware the high prevalence of electrolyte derangements in clinical practice | Le Palma et al. [33] |
| 2 | Achievement of Kidney Disease: Improving Global Outcomes mineral and bone targets between 2010 and 2014 in incident dialysis patients in France: the Photo-Graphe3 study | Fouque et al. [34] |
| 2 | Women and kidney disease: reflections on World Kidney Day 2018: Kidney Health and Women’s Health: a case for optimizing outcomes for present and future generations | Piccoli et al. [35] |
| 3 | Cost of hemodialysis in a public sector tertiary hospital of India | Kaur et al. [36] |
| 3 | Extracorporeal shock wave lithotripsy versus flexible ureterorenoscopy in the treatment of untreated renal calculi | Fankhauser et al. [37] |
| 3 | Do kidney transplantations save money? A study using a before–after design and multiple register-based data from Sweden | Jarl et al. [38] |
| 3 | Sevelamer reduces endothelial inflammatory response to advanced glycation end products | Gregório et al. [39] |
| 3 | Renal recovery after severe acute kidney injury in critically ill myeloma patients: a retrospective study | Joseph et al. [40] |
| 3 | Practical approaches to the management of autosomal dominant polycystic kidney disease patients in the era of tolvaptan | Müller et al. [41] |
| 3 | International Society of Nephrology’s 0by25 initiative (zero preventable deaths from acute kidney injury by 2025): focus on diagnosis of acute kidney injury in low-income countries | Raimann et al. [42] |
| 3 | Lung ultrasonography in end-stage renal disease: moving from evidence to practice—a narrative review | Ross et al. [43] |
| 3 | Cardiovascular effects of metabolic syndrome after transplantation: convergence of obesity and transplant-related factors. | Sgambat et al. [44] |
| 3 | MicroRNAs: a new avenue to understand, investigate and treat immunoglobulin A nephropathy? | Selvaskandan et al. [45] |
Note: As of 18 December 2018, according to Web of Science.